Wainua Side Effects

Generic name: eplontersen

Medically reviewed by Drugs.com. Last updated on Nov 10, 2024.

Note: This document provides detailed information about Wainua.

Applies to eplontersen: sub-q autoinjector Side Effects associated with eplontersen. Some dosage forms listed on this page may not apply specifically to the brand name Wainua.

Applies to eplontersen: sub-q autoinjector.

Side effects include:

Comme adverse effects (≥9%): Decreased vitamin A, vomiting.

For healthcare professionals

Applies to eplontersen: subcutaneous solution.

General adverse events

The most frequently reported side effects included decreased vitamin A and vomiting.^[Ref]

Cardiovascular

• Common (1% to 10%): Atrioventricular (AV) heart block
• Frequency not reported: Complete AV block

AV heart block included at least 1 case of complete AV block.

Gastrointestinal

• Common (1% to 10%): Vomiting

Genitourinary

• Common (1% to 10%): Proteinuria

Local

• Common (1% to 10%): Injection site reactions

Injection site reactions included erythema, pain, and pruritis.

Metabolic

• Very common: Decreased vitamin A (15%)

Decreased vitamin A included vitamin A deficiency and decreased vitamin A.

Ocular

• Common (1% to 10%): Blurred vision, cataract

Further information

Wainua side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.

Medical Disclaimer